tm logo
IBIO
Live/Registered
REGISTERED

on 24 Sep 2024

Last Applicant/ Owned by

11750 Sorrento Valley Road, Suite 200

San Diego

CA

92121

Serial Number

98091758 filed on 19th Jul 2023

Registration Number

7511691 registered on 24th Sep 2024

in the Principal Register

Correspondent Address

Daniel Chalker

Daniel Chalker CHALKER FLORES, LLP

DALLAS, TX 75254

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

IBIO

Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chim Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Research on the subject of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Technical research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made with peptides, proteins, antibodies, and chimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticals, biotechnology, and medicine; Computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligence, medical biotechnology, and pharmaceuticals


First Use Date in General

11th Jul 2023

First Use Date in Commerce

11th Jul 2023

Mark Details


Serial Number

No 98091758

Mark Type

No Service Mark

Attorney Docket Number

No IBIO:3011

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.15.10 -

More than one arrow

24.15.25 -

Other arrows

24.17.12 -

Infinity symbol

26.01.29 -

Helixes

27.03.02 -

Representations of human beings or parts of human beings forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
24th Sep 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
24th Sep 2024REGISTERED-PRINCIPAL REGISTER
09th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Jul 2024PUBLISHED FOR OPPOSITION
19th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30th May 2024APPROVED FOR PUB - PRINCIPAL REGISTER
26th Apr 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
26th Apr 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
26th Apr 2024TEAS/EMAIL CORRESPONDENCE ENTERED
08th Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED